Professor Gordon Wishart listed on #21toWatch People longlist
Check4Cancer is pleased to announce that Professor Gordon Wishart has been listed on the #21toWatch People longlist. Check4Cancer is an award-winning early cancer detection company that has disrupted insured, corporate and self-pay sectors with its rapid access, audited clinical pathways.
The #21toWatch campaign and awards programme looks to showcase the people, companies and ‘things’ across Cambridge and the East of England that are setting the standards of innovation and entrepreneurship across the globe.
Professor Wishart is Check4Cancer’s founder, Chief Executive Officer and Chief Medical Officer. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, he has a strong track record in clinical research and modernisation of cancer diagnosis and treatment. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide. Read more about Professor Wishart’s role at Check4Cancer here.
#21toWatch is dedicated to showcasing and highlighting exciting new entries across all market sectors and celebrating the very best work going on today in the region. The shortlist will be revealed in February 2020 and it will then be independently judged before the Top21 are announced at the awards ceremony in March.
